Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
LYELLyell Immunopharma, Inc.
| Figure | LYELLyell Immunopharma, Inc.FY2025 · Dec |
|---|---|
| Revenue | $36.00K |
| Revenue, yoy | −41.0% |
| Net income | $274.45M |
| Net income, yoy | +20.0% |
| Net margin | -762,355.6% |
| Free cash flow | $150.80M |
| FCF margin | -418,900.0% |
| EPS, diluted | $16.06 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed